• English
  • Eesti

Humaanravimite tähtajatult uuendatud müügiload (03.03)

04.03.2021
Printer-friendly version
Müügiloa hoidjaRavimi nimetusATC koodToimeainedRavimvorm, tugevus, pakendi suurusMüügiloa numberKuuluvused
Alembic Pharmaceuticals Europe LtdOLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICC09DX03

olmesartaanmedoksomiil

+amlodipiin+hüdroklorotiasiid

tabl 40mg+5mg+25mg N7; N10; N14; N28; N30; N50; N56; N84; N90; N98; N500; N961023621R
Alembic Pharmaceuticals Europe LtdOLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICC09DX03

olmesartaanmedoksomiil

+amlodipiin+hüdroklorotiasiid

tabl 20mg+5mg+12,5mg N7; N10; N14; N28; N30; N50; N56; N84; N90; N98; N5001023421R
Alembic Pharmaceuticals Europe LtdOLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICC09DX03

olmesartaanmedoksomiil

+amlodipiin+hüdroklorotiasiid

tabl 40mg+10mg+25mg N7; N10; N14; N28; N30; N50; N56; N84; N90; N98; N5001023821R
Alembic Pharmaceuticals Europe LtdOLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICC09DX03

olmesartaanmedoksomiil

+amlodipiin+hüdroklorotiasiid

tabl 40mg+5mg+12,5mg N7; N10; N14; N28; N30; N50; N56; N84; N90; N98; N5001023521R
Alembic Pharmaceuticals Europe LtdOLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICC09DX03

olmesartaanmedoksomiil

+amlodipiin+hüdroklorotiasiid

tabl 40mg+10mg+12,5mg N7; N10; N14; N28; N30; N50; N56; N84; N90; N98; N5001023721R
Alembic Pharmaceuticals Europe LtdTELMISARTAN/AMLODIPINE ALEMBICC09DB04telmisartaan+amlodipiintabl 40mg+5mg N7; N10; N14; N28; N30; N56; N90; N98; N3601024121R
Alembic Pharmaceuticals Europe LtdTELMISARTAN/AMLODIPINE ALEMBICC09DB04telmisartaan+amlodipiintabl 40mg+10mg N7; N10; N14; N28; N30; N56; N90; N98; N3601024221R
Alembic Pharmaceuticals Europe LtdTELMISARTAN/AMLODIPINE ALEMBICC09DB04telmisartaan+amlodipiintabl 80mg+5mg N7; N10; N14; N28; N30; N56; N90; N98; N3601024321R
Alembic Pharmaceuticals Europe LtdTELMISARTAN/AMLODIPINE ALEMBICC09DB04telmisartaan+amlodipiintabl 80mg+10mg N7; N10; N14; N28; N30; N56; N90; N98; N3601024421R
Auxilia Pharma OÜFOLIC ACID AUXILIAB03BB01foolhapetabl 1mg N30; N50; N60; N90; N1001023221R
Auxilia Pharma OÜFOLIC ACID AUXILIAB03BB01foolhapetabl 5mg N30; N50; N60; N90; N1001023321R
Laboratoires TheaFIXOPOSTS01ED84timolool+latanoprostsilmatilgad, lahus 5mg+50mcg/1ml 2,5ml N1; 6ml N11023121R
Orpha-Devel Handels und Vertriebs GmbHTRESUVIB01AC21treprostiniilinf lahus 1mg/ml 10ml N11024521R
Orpha-Devel Handels und Vertriebs GmbHTRESUVIB01AC21treprostiniilinf lahus 2,5mg/ml 10ml N11024621R
Orpha-Devel Handels und Vertriebs GmbHTRESUVIB01AC21treprostiniilinf lahus 5mg/ml 10ml N11024721R
Orpha-Devel Handels und Vertriebs GmbHTRESUVIB01AC21treprostiniilinf lahus 10mg/ml 10ml N11024821R
Sandoz Pharmaceuticals d.d.AIRBUFO FORSPIROR03AK07formoterool+budesoniidannustatud inhal pulber 9µg+320µg/annuses 60annust N1; 60annust N2; 60annust N3; 60annust N4; 60 annust N61022821R
Sandoz Pharmaceuticals d.d.EPROCLIVA10BD07metformiin+sitagliptiintabl 850mg+50mg N7; N10; N14; N20; N28; N30; N50; N56; N60; N90; N100; N112; N168; N180; N1961022921R
Sandoz Pharmaceuticals d.d.EPROCLIVA10BD07metformiin+sitagliptiintabl 1000mg+50mg N7; N10; N14; N20; N28; N30; N50; N56; N60; N90; N100; N112; N168; N180; N1961023021R
SIA “LMP”PERMETRIIN LMPP03AC04permetriingeel 50mg/g 30g N1; 60g N11024021K
Zentiva k.s.ONTIPRIAR03BB04tiotroopiuminhal pulber kapslis 18µg N30; N60; N901023921R
       
       
03. märtsil 2021 said teisese tähtajatu müügiloa järgmised humaanravimid:     
       
Müügiloa hoidjaRavimi nimetus   ATC koodToimeainedRavimvorm, tugevus, pakendi suurusMüügiloa numberKuuluvused
First Pharma OÜCATHEJELL LIDOCAINN01BB86lidokaiin+kloorheksidiingeel 20mg+0,5mg/g 12,5g N5; 12,5g N251022721R
UAB "Lex ano"DERMOVATED07AD01klobetasoolnahalahus 500µg/ml 25ml N11021721R
UAB "Lex ano"PLAQUENILP01BA02hüdroksüklorokviintabl 200mg N301021821R
UAB "Lex ano"CLARITINER06AX13loratadiintabl 10mg N301022021K
UAB "Lex ano"XEFOM01AC05lornoksikaamtabl 8mg N201021921R
UAB Ideal Trade LinksKLOTRIMASOOL GSKG01AF02klotrimasoolvagin tabl 100mg N61022221R
UAB Ideal Trade LinksKLOTRIMASOOL GSKD01AC01klotrimasoolkreem 10mg/g 20g N11022321K
UAB Ideal Trade LinksCOAXILN06AX14tianeptiinkaetud tabl 12,5mg N301022421R
UAB Ideal Trade LinksNUROFEN FORTE ORANGEM01AE01ibuprofeensuukaudne susp 40mg/ml 100ml N11022621K
UAB Ideal Trade LinksNUROFEN FORTE STRAWBERRYM01AE01ibuprofeensuukaudne susp 40mg/ml 100ml N11022121K
UAB Ideal Trade LinksCO-PRENESSAC09BA04perindopriil+indapamiidtabl 8mg+2,5mg N301022521R
       
       
03. märtsil 2021 uuendati müügiluba tähtajatult järgmistel humaanravimitel:    
       
Müügiloa hoidjaRavimi nimetus   ATC koodToimeainedRavimvorm, tugevus, pakendi suurusMüügiloa numberKuuluvused
Accord Healthcare B.V.DULOXETINE ACCORDN06AX21duloksetiingastroresistentne kapsel 30mg N7; N28; N98; N10; N14; N30; N90; N100887015R
Accord Healthcare B.V.DULOXETINE ACCORDN06AX21duloksetiingastroresistentne kapsel 60mg N10; N14; N28; N30; N90; N98; N100887115R
Accord Healthcare B.V.CINACALCET ACCORDH05BX01tsinakaltseettabl 30mg N14; N28; N84892315R
Accord Healthcare B.V.CINACALCET ACCORDH05BX01tsinakaltseettabl 60mg N14; N28; N84892415R
Accord Healthcare B.V.CINACALCET ACCORDH05BX01tsinakaltseettabl 90mg N14; N28; N84892515R
Accord Healthcare B.V.TOLTERODINE ACCORDG04BD07tolterodiinprolong caps 4mg N7; N10; N14; N20; N28; N30; N49; N50; N56; N60; N80; N84; N90; N98; N100; N112; N160; N200; N280; N320919316R
Accord Healthcare B.V.TOLTERODINE ACCORDG04BD07tolterodiinprolong caps 2mg N7; N10; N14; N20; N28; N30; N49; N50; N56; N60; N80; N84; N90; N98; N100; N112; N160; N200; N280; N320919216R
Actavis Group PTC ehfTADALAFIL ACTAVISG04BE08tadalafiiltabl 5mg N4; N14; N28; N30911116R
Actavis Group PTC ehfTADALAFIL ACTAVISG04BE08tadalafiiltabl 20mg N2; N4; N8; N12; N56911216R
AstraZeneca ABSYMBICORTR03AK07formoterool+budesoniidinhal aeros, susp 4,5µg+160µg/pihustuses  N120910316R
CSL Behring GmbHBERIATEB02BD02VIII hüübimisfaktorinj/inf lahuse pulber ja lahusti 250RÜ N1+ lahusti 2,5ml997119R
CSL Behring GmbHBERIATEB02BD02VIII hüübimisfaktorinj/inf lahuse pulber ja lahusti 500RÜ N1 + lahusti 5ml997219R
CSL Behring GmbHBERIATEB02BD02VIII hüübimisfaktorinj/inf lahuse pulber ja lahusti 1000RÜ N1 + lahusti 10ml997319R
CSL Behring GmbHBERIATEB02BD02VIII hüübimisfaktorinj/inf lahuse pulber ja lahusti 2000RÜ N1 + lahusti 10ml997419R
Gedeon Richter Plc.DONAXYLG01AC05dekvaliinvagin tabl 10mg N6921916R
KRKA, d.d., Novo mestoFUROCEFJ01DC02tsefuroksiimtabl 250mg N10; N12; N14; N16; N20; N24; N15; N8875315R
KRKA, d.d., Novo mestoFUROCEFJ01DC02tsefuroksiimtabl 500mg N10; N12; N14; N16; N20; N24; N15; N8875215R
Teva Pharma B.V.SILDENAFIL TEVA PHARMAG04BE03sildenafiiltabl 20mg N30; N90; N300923516R